Skip to main content
. Author manuscript; available in PMC: 2007 Oct 22.
Published in final edited form as: J Allergy Clin Immunol. 2005 Sep;116(3):586–593. doi: 10.1016/j.jaci.2005.04.035

FIG 2.

FIG 2

Relationship between lung function and severity of EIB measured on the basis of the AUC30 (A) and lung function response to a short-acting β2-agonist and severity of EIB (B). No relationship was identified between either of these 2 physiologic parameters and the severity of EIB.